Similar articles

• [Immunotherapy of hepatocellular carcinoma].

  Geissler M, Mohr L, Blum HE. Geissler M, et al. Dtsch Med Wochenschr. 2001 Dec 21;126(51-52):1464-6. doi: 10.1055/s-2001-19215. Dtsch Med Wochenschr. 2001. PMID: 11753738 Review. German. No abstract available.
• Comparative analysis of DC fused with allogeneic hepatocellular carcinoma cell line HepG2 and autologous tumor cells as potential cancer vaccines against hepatocellular carcinoma.

  Cao DY, Yang JY, Yue SQ, Tao KS, Song ZS, Wang DS, Yang YL, Dou KF. Cao DY, et al. Cell Immunol. 2009;259(1):13-20. doi: 10.1016/j.cellimm.2009.05.007. Epub 2009 May 27. Cell Immunol. 2009. PMID: 19545862
• [Immune therapy against hepatocellular carcinoma using gene-modified tumor cells].

  Miyagi T, Tatsumi T, Hayashi N. Miyagi T, et al. Nihon Rinsho. 2001 Oct;59 Suppl 6:688-92. Nihon Rinsho. 2001. PMID: 11762038 Review. Japanese. No abstract available.
• Dendritic cell as therapeutic vaccines against tumors and its role in therapy for hepatocellular carcinoma.

  Sun K, Wang L, Zhang Y. Sun K, et al. Cell Mol Immunol. 2006 Jun;3(3):197-203. Cell Mol Immunol. 2006. PMID: 16893500 Review.
• [Current status of immuno-gene therapy for hepatocellular carcinoma].

  Ye S. Ye S. Zhonghua Gan Zang Bing Za Zhi. 2002 Dec;10(6):407-8. Zhonghua Gan Zang Bing Za Zhi. 2002. PMID: 12502436 Chinese. No abstract available.